Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes
Objectives: Fulminant myocarditis (FM) is a rapidly progressive and frequently fatal form of myocarditis that has been difficult to classify. This study aims to compare the clinical characteristics, treatments and outcomes in patients with fulminant giant cell myocarditis (FGCM) and fulminant lympho...
Enregistré dans:
Auteurs principaux: | Yuxiao Hu, Jie Ren, Xueqi Dong, Di Zhang, Yi Qu, Chunxue Yang, Yang Sun, Jinghui Li, Fang Luo, Wei Wang, Huanhuan Wang, Ping Qing, Shihua Zhao, Jie Huang, Litian Yu, Yaxin Liu, Huiqiong Tan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cde15553d0034d1a80af5aa95e77c11a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pheochromocytoma presenting as fulminant myocarditis mimicking COVID‐19 pneumonia
par: Imen Rojbi, et autres
Publié: (2021) -
Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
par: Shelly Meron Grossman, et autres
Publié: (2021) -
Fatal fulminant HSV-2 myocarditis: A complicated presentation
par: Daniele Colombo, et autres
Publié: (2022) -
Viral Myocarditis—From Pathophysiology to Treatment
par: Heinz-Peter Schultheiss, et autres
Publié: (2021) -
The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis
par: Chao Liu, et autres
Publié: (2021)